Ken Griffin Chroma Dex Corp. Put Options Transaction History

Citadel Advisors LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$2.44 - $4.32 $488 - $864	-200 Reduced 3.17%	6,100 $16,000
Q1 2024 May 15, 2024	BUY	$1.36 - $3.84 $8,568 - $24,192	6,300 New	6,300 $21,000
Q2 2023 Aug 14, 2023	SELL	$1.31 - $1.79 $1,179 - $1,611	-900 Reduced 30.0%	2,100 $3,000
Q1 2023 May 15, 2023	BUY	$1.48 - $2.19 $296 - $438	200 Added 7.14%	3,000 $4,000
Q4 2022 Feb 14, 2023	BUY	$1.25 - $1.94 $3,500 - $5,432	2,800 New	2,800 $4,000

16.4M

91.7K

18.9K

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $243M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.